Clinical Trial

Optical Diagnosis of Neoplasia Using Artificial Intelligence

Study acronym: FAIR
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 5, 2025 (before its estimated November 2025 completion). Its status may not reflect the trial's current state.
Summary
Computer-aided diagnosis (CADx) for colonoscopy aims to enhance optical diagnosis but often underperforms when used alongside humans due to under-reliance on AI. Psychological interventions like cognitive forcing, such as delaying CADx suggestions, may improve human-AI interaction by fostering critical assessment. However, their impact on patient-important outcomes remains unexplored. The investigators will conduct an ex-vivo randomized study with 70 endoscopists assessing 100 polyp videos (≤5 mm) using a CADx tool (GI Genius, Medtronic). Participants will be randomized to either: * Intervention group: CADx suggestions will be shown in the last 3 seconds of the 15 second polyp video. * Control group: CADx suggestions will be shown in real-time throughout the playback of the 15 second polyp video. The primary endpoint is sensitivity for high-confidence neoplasia detection, with secondary endpoints assessing endoscopists' reliance on AI. CADx systems on the market function in various ways, such as real-time, delayed, or on-demand diagnosis. Our study aims to inform users and manufacturers whether cognitive forcing through delayed CADx suggestions enhances human-AI interaction, leading to improved clinical outcomes.
Trial Details
NCT Number NCT07158203
Lead Sponsor Fundacin Biomedica Galicia Sur
Conditions Polyps Colorectal, Colonoscopy, Optical Biopsy, Colorectal Cancer Control and Prevention, Colorectal Cancer Screening, Behavior Change, Psychological Factors, Psychological Intervention
Enrollment 70 participants
Start Date 2025-09
Primary Completion 2025-11 (estimated)
Study Completion 2025-12 (estimated)
Updated on ClinicalTrials.gov 2025-09-05